Literature DB >> 159352

The natural history of hypertrophic cardiomyopathy in infants of diabetic mothers.

G L Way, R R Wolfe, E Eshaghpour, R L Bender, R B Jaffe, H D Ruttenberg.   

Abstract

Eleven infants of diabetic mothers with hypertrophic cardiomyopathy have been followed for 30 to 40 months. All infants presented with cardiorespiratory distress and were found to have disproportionate septal hypertrophy on echocardiogram. Cardiac catheterization was done in four infants; three had significant subaortic obstruction. One infant had remarkable improvement after treatment with propranolol. Two infants who received digoxin did poorly and responded favorably to cessation of therapy. The natural history of HCM-IDM appears to be benign, with a resolution of symptoms within two to four weeks and a resolution of septal hypertrophy within two to 12 months. Most of the infants need only supportive care; if pharmacologic intervention is deemed necessary, propranolol appears to be the drug of choice. The natural history of this entity is that of spontaneous regression of symptoms and septal hypertrophy irrespective of therapy.

Entities:  

Mesh:

Year:  1979        PMID: 159352     DOI: 10.1016/s0022-3476(79)80302-9

Source DB:  PubMed          Journal:  J Pediatr        ISSN: 0022-3476            Impact factor:   4.406


  19 in total

1.  Transient right sided hypertrophic cardiomyopathy in an infant born to a diabetic mother.

Authors:  A Akcoral; B Oran; V Tavli; H Oren; N T Cevik
Journal:  Indian J Pediatr       Date:  1996 Sep-Oct       Impact factor: 1.967

Review 2.  Clues in diagnosing congenital heart disease.

Authors:  A J Moss
Journal:  West J Med       Date:  1992-04

3.  Echocardiographic assessment of infants born to diabetic mothers.

Authors:  A K Deorari; A Saxena; M Singh; S Shrivastava
Journal:  Arch Dis Child       Date:  1989-05       Impact factor: 3.791

4.  Neonatal hyperinsulinism secondary to maternal intake of high-sugar drinks.

Authors:  Nicol Jon West; Matthew Thorpe
Journal:  BMJ Case Rep       Date:  2011-07-15

5.  Fatal hypertrophic cardiomyopathy in an infant of a diabetic mother.

Authors:  J N McMahon; P J Berry; H S Joffe
Journal:  Pediatr Cardiol       Date:  1990-10       Impact factor: 1.655

6.  Use of vasopressin in neonatal hypertrophic obstructive cardiomyopathy: case series.

Authors:  Stephanie M Boyd; Kristin L Riley; Regan E Giesinger; Patrick J McNamara
Journal:  J Perinatol       Date:  2020-09-19       Impact factor: 2.521

7.  Features and outcomes in utero and after birth of fetuses with myocardial disease.

Authors:  Vlasta Fesslova; Maurizio Mongiovì; Salvatore Pipitone; Jelena Brankovic; Laura Villa
Journal:  Int J Pediatr       Date:  2010-10-03

8.  Specificity of systolic anterior motion of anterior mitral leaflet for hypertrophic cardiomyopathy. Prevalence in large population of patients with other cardiac diseases.

Authors:  B J Maron; J S Gottdiener; L W Perry
Journal:  Br Heart J       Date:  1981-02

9.  Hypertrophic cardiomyopathy in neonates with congenital hyperinsulinism.

Authors:  TingTing Huang; Andrea Kelly; Susan A Becker; Meryl S Cohen; Charles A Stanley
Journal:  Arch Dis Child Fetal Neonatal Ed       Date:  2013-02-01       Impact factor: 5.747

10.  Troponin T and NT ProBNP Levels in Gestational, Type 1 and Type 2 Diabetic Mothers and Macrosomic Infants.

Authors:  Mustafa Kurthan Mert; Mehmet Satar; Nazan Özbarlas; Akgün Yaman; Fatma Tuncay Özgünen; Hüseyin Selim Asker; Eren Kale Çekinmez; Tamer Tetiker
Journal:  Pediatr Cardiol       Date:  2015-08-13       Impact factor: 1.655

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.